Haleon PLC (GB:HLN) has released an update.
Haleon PLC has updated its base prospectus for the £10 billion Euro Medium Term Note Programme, which is now available for interested parties on the company’s website. The company is a leading global player in consumer health, with a portfolio of well-known brands across various health categories. The updated prospectus is targeted towards residents of specific countries, and Haleon advises verifying eligibility before reliance.
For further insights into GB:HLN stock, check out TipRanks’ Stock Analysis page.
